CN104030977B - 一种达比加群酯中间体的制备方法 - Google Patents
一种达比加群酯中间体的制备方法 Download PDFInfo
- Publication number
- CN104030977B CN104030977B CN201310074041.0A CN201310074041A CN104030977B CN 104030977 B CN104030977 B CN 104030977B CN 201310074041 A CN201310074041 A CN 201310074041A CN 104030977 B CN104030977 B CN 104030977B
- Authority
- CN
- China
- Prior art keywords
- preparation
- methylamine
- solution
- compound
- alkylol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310074041.0A CN104030977B (zh) | 2013-03-07 | 2013-03-07 | 一种达比加群酯中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310074041.0A CN104030977B (zh) | 2013-03-07 | 2013-03-07 | 一种达比加群酯中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104030977A CN104030977A (zh) | 2014-09-10 |
CN104030977B true CN104030977B (zh) | 2016-05-04 |
Family
ID=51462000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310074041.0A Active CN104030977B (zh) | 2013-03-07 | 2013-03-07 | 一种达比加群酯中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104030977B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10112901B2 (en) | 2014-07-03 | 2018-10-30 | Shanghai Institute Of Pharmaceutical Industry | Method for preparing dabigatran etexilate intermediate, and intermediate compound |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102224143A (zh) * | 2008-09-25 | 2011-10-19 | 贝林格尔.英格海姆国际有限公司 | 作为抗炎药的1h-苯并咪唑-5-甲酰胺 |
CN102633713A (zh) * | 2012-03-22 | 2012-08-15 | 南京工业大学 | 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法 |
WO2012152855A1 (en) * | 2011-05-11 | 2012-11-15 | Medichem S.A. | Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6448281B1 (en) * | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
CN105753858B (zh) * | 2010-07-02 | 2019-04-30 | Aska制药株式会社 | 杂环化合物及p27Kip1分解抑制剂 |
-
2013
- 2013-03-07 CN CN201310074041.0A patent/CN104030977B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102224143A (zh) * | 2008-09-25 | 2011-10-19 | 贝林格尔.英格海姆国际有限公司 | 作为抗炎药的1h-苯并咪唑-5-甲酰胺 |
WO2012152855A1 (en) * | 2011-05-11 | 2012-11-15 | Medichem S.A. | Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers |
CN102633713A (zh) * | 2012-03-22 | 2012-08-15 | 南京工业大学 | 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法 |
Non-Patent Citations (2)
Title |
---|
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors;Norbert H. Hauel等;《Journal of Medicinal Chemistry》;20020326;第45卷(第9期);第1757-1766页 * |
甲磺酸达比加群酯的合成;程青芳,等;《中国新药杂志》;20121231;第21卷(第1期);第88-91页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104030977A (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2520215C2 (ru) | Способ получения и выделения 2-ациламино-3-дифенилпропионовой кислоты | |
CN103539795A (zh) | 阿哌沙班的多晶型及其制备方法 | |
CN107235958A (zh) | 一种制备PARP抑制剂Niraparib的合成方法 | |
CN103467495A (zh) | 一种头孢克肟化合物的制备方法 | |
CN104447868A (zh) | 一种富马酸替诺福韦二吡呋酯的制备方法 | |
CN104030977B (zh) | 一种达比加群酯中间体的制备方法 | |
CN102746207B (zh) | 一种奥拉西坦的合成方法 | |
CN103922999B (zh) | 一种达比加群酯中间体的制备方法及中间体化合物 | |
CN103833772B (zh) | 一种头孢菌素的合成方法 | |
CN102093355B (zh) | 一种c-3酰基化吲哚嗪化合物及其制备方法 | |
CN106279207A (zh) | 一种头孢地尼的合成方法 | |
JP7307282B2 (ja) | ベンゾ2-アザスピロ[4.4]ノナン系化合物及びその使用 | |
CN108033948A (zh) | 一种德拉沙星及其中间体的制备 | |
CN105566296A (zh) | 一种制备达比加群酯酰胺化杂质的方法 | |
EP3165521B1 (en) | Method of preparing dabigatran etexilate intermediate and intermediate compound | |
CN103980293B (zh) | 3-乙烯基-7-(噻唑甲氧亚氨基)头孢烷酸的制备方法 | |
CN104478811B (zh) | 一种非马沙坦中间体的制备方法 | |
CN102757398A (zh) | 一类噁唑烷酮衍生物的制备方法 | |
CN106946846B (zh) | 达比加群酯新中间体及其制备方法 | |
CN102584855B (zh) | 一种改进的头孢噻呋的制备方法 | |
CN103012264A (zh) | 3-取代氨基-六氢-1h-氮杂环庚烷的拆分方法 | |
JP6126102B2 (ja) | 純粋なS−(−)−9−フルオロ−6,7−ジヒドロ−8−(4−ヒドロキシピペリジン−1−イル)−5−メチル−1−オキソ−1H,5H−ベンゾ[i,j]キノリジン−2−カルボン酸L−アルギニン塩4水和物およびその製造方法 | |
WO2010089643A1 (en) | An improved process for the preparation of paliperidone | |
CN102464605B (zh) | 4-硝基-哌啶衍生物的制备方法 | |
KR20230166114A (ko) | 시퀀싱을 위한 뉴클레오타이드 유사체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Yajun Inventor after: Dan Hanbin Inventor after: Zhu Xueyan Inventor after: Yuan Zhedong Inventor after: Yu Xiong Inventor after: Jiang Hua Inventor after: Zhang Xiquan Inventor after: Wang Shanchun Inventor before: Guo Yajun Inventor before: Dan Hanbin Inventor before: Zhu Xueyan Inventor before: Yuan Zhedong Inventor before: Yu Xiong Inventor before: Jiang Hua |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160516 Address after: 200040 Beijing West Road, Shanghai, No. 1320, No. Patentee after: Shanghai Institute of pharmaceutical industry Patentee after: China State Institute of Pharmaceutical Industry Patentee after: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Address before: 200040 Beijing West Road, Shanghai, No. 1320, No. Patentee before: Shanghai Institute of pharmaceutical industry Patentee before: China State Institute of Pharmaceutical Industry |